Market Challenges And Opportunities

Global Fertility Test Market Drivers:

Declining fertility rates to augment market growth

One of the key factors expected to augment the growth of the global fertility testmarket over the forecast period is the declining fertility rates among men and women across the world. Worldwide, fertility has fallen from an average of 5 births per woman in 1950 to 2.3 births per woman in 2021, an indication of the increasing control that individuals are able to exercise over their reproductive lives. According to the United Nation's World Population Prospects 2022 (WPP) report, the global fertility rate, which stood at 2.3 overall in 2021, will hit the demographic tipping point of 2.1 by 2050, due to a globally synchronized decline in birth rates.

Increasing awareness among people to propel market growth

Another factor driving the growth of the global fertility testmarket is the rising awareness among people about fertility testing devices. For instance, due to the increasing awareness about fertility testing in both developed and developing countries, there has been an increase in the fertility rate among the population over the years. Several governments and organizations also organize camps and events to raise awareness among people about fertility testing devices. The world Infertility Awareness Month is celebrated every June to increase awareness regarding numerous infertility issues faced by couples/individuals across the world.

Global Fertility Test Market Opportunities:

Increasing demand or adoption of fertility testing devices is expected to provide significant growth opportunities for players in the global fertility testmarket. For instance, with the rising awareness among people about fertility testing, the demand and/or adoption of fertility testing devices is also increasing with a rapid pace. In August 2021, Inito, a home fertility test, launched in the U.S. The Inito device, paired with a smartphone application, is an at-home testing device that measures the actual hormone values for estrogen, luteinizing hormone, and progesterone, giving the users data to guide decisions through the conception process.

Increasing prevalence of PCOS (polycystic ovary syndrome) among women is expected to provide significant growth opportunities for players in the global fertility testmarket. For instance, PCOS can affect a person's fertility in different ways. Ovulation problems are usually the primary cause of infertility in women with PCOS. Many women have PCOD/PCOS but are not aware of it, which can result in infertility. According to the Centers for Disease Control and Prevention (CDC), PCOS is one of the most common causes of female infertility, affecting 6% to 12% (as many as 5 million) of women of reproductive age in the United States.

Global Fertility Test Market Restaints:

High cost of testing monitors to hinder market growth

One of the key factors expected to hamper the growth of the global fertility testmarket is the high cost of fertility testing monitors. For instance, fertility monitors are an effective way to measure temperature and hormone levels to predict ovulation and peak fertility. However, they cost of the fertility monitor is high. Fertility testing monitors can be found in the lowest price of US$ 13 and can range up to US$ 130. The average price of the fertility testing monitor with good quality ranges around US$ 70, and this price segment cannot be considered affordable for all consumers.

Lack of predictive accuracy to hamper market growth

Another factor which is hampering the growth of the fertility testmarket is the lack of predictive accuracy to confirm ovulation. For instance, the ovulation monitors are used to determine the time in the menstrual cycle when changes of getting pregnant are high. The test detects a rise in LH in the urine as the rise in this hormone signals the ovary to release egg. If used accurately, the monitor can deliver 99% accuracy. However, the monitor may not give reliable results for women with the PCOS as the LH level or estrogen hormone level is constantly high or multiple peaks can be seen. The results therefore can falsely reflect whether or not the female has ovulated.